醫華生技
創立於2015年,以半導體及電子產業跨足生技醫療領域
專注於生物技術與設備研發,應用於(單)細胞層級的蛋白及基因研究
並致力於精準醫療,提供更準確的醫療服務。
Established in 2015, CytoAurora Biotechnology actively promotes cross-field integration, hoping to introduce the biotechnology and medical industry with the advantages of Taiwan's semiconductor and electronics industries, and is committed to the research and development of innovative cell biotechnology and equipment, which can be applied to protein and gene research at the single-cell level. Aim at the research and development in the field of precision medicine, provide more accurate medical services, and give back to the society.
CES
Jan.9-12 2024
Booths:TAIWAN TECH ARENA [Digital Health] DH14
Venetian Expo, Hall G — 62700 — Eureka Park
跨領域技術
Semiconductor technology
semiconductor biochip
Ability to analyze biological cells quickly and accurately
01.半導體技術
微流道半導體生物晶片
能快速準確地分析生物細胞
03.分子病理與化學
03.分子病理與化學
Molecular pathology
and chemistry
運用腫瘤細胞分子
進行病理分析和檢測
Using tumor cell molecules
Perform pathological analysis and testing
02.人工智慧分析
AI analysis
自行開發軟體 準確識別細胞
提供精確的診斷結果
Self-developed software to accurately identify cells
Provide accurate diagnostic results
Precision machinery and optics
自行研發與製造細胞檢測平台
提供最優化的解決方法
04.精密機械與光學
Self-developed and manufactured cell detection platform
Provide optimized solutions
CES
項目創新獎
Innovation Award
RESI
全球第二名
Innovator's Pitch Challenge
Top 2
MEDICA
全球TOP十二強
Top 12 in MEDICA
榮獲國內外大獎肯定
Award
AI影像判讀
&掃描儀
AI interpretation
&Scanner
AI analysis tool
AI分析工具
Multifunctional micro scanner
多功能微型掃描儀
CMS系列
CMS series
業界第一個
液體活檢和組織切片系統
The world's 1st system for liquid biopsy and tissue sections
Applications and benefits:
應用/優勢
快速、準確
腫瘤微環境
數據一致性
減少人為錯誤
液體活檢(例如免疫疾病分析)
Faster more accurate
Reduced human errors
Data consistency
Traditional pathology to ai digital pathology
Tumor microenvironment
Liquid biopsy(e.g. Immune disease analysis)